155 related articles for article (PubMed ID: 7901232)
1. Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin.
Ueki Y; Nagata M; Miyake S; Tominaga Y
J Clin Immunol; 1993 Jul; 13(4):279-87. PubMed ID: 7901232
[TBL] [Abstract][Full Text] [Related]
2. Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes.
Lisowska KA; Dębska-Ślizień A; Jasiulewicz A; Heleniak Z; Bryl E; Witkowski JM
J Clin Immunol; 2012 Feb; 32(1):189-200. PubMed ID: 21993694
[TBL] [Abstract][Full Text] [Related]
3. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.
Costa E; Lima M; Alves JM; Rocha S; Rocha-Pereira P; Castro E; Miranda V; do SF; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
J Clin Immunol; 2008 May; 28(3):268-75. PubMed ID: 18205031
[TBL] [Abstract][Full Text] [Related]
4. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
Pascual J; Teruel JL; Moya JL; Liaño F; Jiménez-Mena M; Ortuño J
Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of oral submucous fibrosis.
Haque MF; Harris M; Meghji S; Speight PM
J Oral Pathol Med; 1997 Feb; 26(2):75-82. PubMed ID: 9049906
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies.
Borges A; Borges M; Fernandes J; Nascimento H; Sameiro-Faria M; Miranda V; Reis F; Belo L; Costa E; Santos-Silva A
Ren Fail; 2011; 33(2):138-43. PubMed ID: 21332334
[TBL] [Abstract][Full Text] [Related]
7. T lymphocyte subsets and NK cell cytotoxicity in chronic hemodialysis patients. The effect of recombinant human erythropoietin (rHu-EPO) treatment.
Baj Z; Pokoca L; Majewska E; Luciak M; Tchórzewski H
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):201-6. PubMed ID: 1300984
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.
Lisowska KA; Debska-Slizien A; Radzka M; Witkowski JM; Rutkowski B; Bryl E
Artif Organs; 2010 Mar; 34(3):E77-84. PubMed ID: 20447038
[TBL] [Abstract][Full Text] [Related]
9. Effect of iron loading on peripheral blood lymphocyte subsets and on circulating cytokine levels in iron-depleted hemodialysis patients receiving erythropoietin.
Tsouchnikas I; Tsilipakou M; Daniilidis M; Kyriazis G; Pasadakis P; Parapanissiou E; Vargemezis V; Tsakiris D
Nephron Clin Pract; 2007; 107(3):c97-102. PubMed ID: 17890877
[TBL] [Abstract][Full Text] [Related]
10. The influence of recombinant human erythropoietin on apoptosis and cytokine production of CD4+ lymphocytes from hemodialyzed patients.
Lisowska KA; Dębska-Ślizień A; Jasiulewicz A; Daca A; Bryl E; Witkowski JM
J Clin Immunol; 2013 Apr; 33(3):661-5. PubMed ID: 23180360
[TBL] [Abstract][Full Text] [Related]
11. [Lymphocyte subpopulations in maintenance hemodialysis patients receiving recombinant human erythropoietin].
Kaneko Y; Motomiya Y; Arai K; Kagebayashi Y; Okada H; Sasaki K; Yoneda T; Yoshida K; Ozono S; Hirao Y
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):743-9. PubMed ID: 8377287
[TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human erythropoietin on T lymphocyte subsets in hemodialysis patients.
Collart FE; Dratwa M; Wittek M; Wens R
ASAIO Trans; 1990; 36(3):M219-23. PubMed ID: 2147556
[TBL] [Abstract][Full Text] [Related]
13. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.
Gessl A; Waldhäusl W
Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR+CD3+ and CD8+ cells are increased but CD4+CD45RA+ cells are reduced in the peripheral blood in human scrub typhus.
Ikeda M; Takahashi H; Yoshida S
Clin Immunol Immunopathol; 1994 Sep; 72(3):402-4. PubMed ID: 7914843
[TBL] [Abstract][Full Text] [Related]
15. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
[TBL] [Abstract][Full Text] [Related]
16. [Numerical and functional alterations in T and B lymphocyte subpopulations in CAPD patients treated with recombinant human erythropoietin].
Tanabe R
Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1159-68. PubMed ID: 7815748
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the subsets of lymphocytes and their activated status in patients with myelodysplastic syndrome].
Yang J; Wang C; Xie KC; Yan SK; Gao YR; Cai Q; Qin YW; Wan LP; Cai Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):708-13. PubMed ID: 16928305
[TBL] [Abstract][Full Text] [Related]
18. Persistent activation of CD8+ T-cells characterizes prediabetic twins.
Peakman M; Leslie RD; Alviggi L; Hawa M; Vergani D
Diabetes Care; 1996 Nov; 19(11):1177-84. PubMed ID: 8908376
[TBL] [Abstract][Full Text] [Related]
19. No effect of transfusion transmitted virus viremia on the distribution and activation of peripheral lymphocytes in hemodialyzed patients.
Fodor B; Ladányi E; Aleksza M; Takács M; Lakos G; Arkossy O; Koós A; Nagy A; Széll J; Klenk N; Sárváry E; Sipka S
Nephron; 2002 Dec; 92(4):933-7. PubMed ID: 12399644
[TBL] [Abstract][Full Text] [Related]
20. Decreased total numbers of peripheral blood lymphocytes with elevated percentages of CD4+CD45RO+ and CD4+CD25+ of T-helper cells in non-segmental vitiligo.
Mahmoud F; Abul H; Haines D; Al-Saleh C; Khajeji M; Whaley K
J Dermatol; 2002 Feb; 29(2):68-73. PubMed ID: 11890298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
